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Abstract
The Patient Health Questionnaire (PHQ-9) is a widely-used screening tool for depression in
primary care settings. The purpose of the present study is to identify the factor structure of
the PHQ-9 and to examine the measurement invariance of this instrument across different
sociodemographic groups and over time in a sample of primary care patients in Spain.
Data came from 836 primary care patients enrolled in a randomized controlled trial (PsicAP
study) and a subsample of 218 patients who participated in a follow-up assessment at 3
months. Confirmatory factor analysis (CFA) was used to test one- and two-factor structures
identified in previous studies. Analyses of multiple-group invariance were conducted to
determine the extent to which the factor structure is comparable across various demo-
graphic groups (i.e., gender, age, marital status, level of education, and employment situa-
tion) and over time. Both one-factor and two-factor re-specified models met all the pre-
established fit criteria. However, because the factors identified in the two-factor model were
highly correlated (r = .86), the one-factor model was preferred for its parsimony. Multi-group
CFA indicated measurement invariance across different demographic groups and across
time. The present findings suggest that physicians in Spain can use the PHQ-9 to obtain a
global score for depression severity in different demographic groups and to reliably monitor
changes over time in the primary care setting.
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Introduction
Depression is one of the most common mental disorders around the world. Globally, the total
number of people with depression was estimated to exceed 300 million in 2015 [1]. Depression
is responsible for more ‘years lost’ to disability than any other condition in the world (accord-
ing to WHO estimates, 7.5% of all years lived with disability in 2015), and it is a major contrib-
utor to the overall global burden of disease [1]. Depression is ranked by WHO as the single
largest contributor to global disability. The lifetime prevalence for major depressive disorder
(MDD) has been estimated at 12.8% in Europe (ESEMeD project) [2] and 10.6% in Spain [3].
The Diagnostic and Assessment Study of Mental Disorders in Primary Care (DASMAP),
based on 3,815 patients from 77 primary care centres in Spain, found that almost 30% reported
a lifetime history of MDD, with 9.6% experiencing MDD in the past 12 months [4]. Neverthe-
less, epidemiological and clinical studies show that general practitioners (GP) fail to diagnose a
large part of patients suffering from depression [5]. In fact, studies conducted in Spanish pri-
mary care settings show that nearly 78% of the patients with depression are misdiagnosed,
indicating that only approximately one-quarter of cases diagnosed as depressed by GPs are
correctly diagnosed [6]. Moreover, a high proportion of these individuals remain untreated
[7]: in Spain, only approximately one-third of patients with MDD receive "minimally-ade-
quate" treatment [8].
The Patient Health Questionnaire Depression Scale (PHQ-9) [9] is well-validated instru-
ment used to quickly diagnose depression, assess severity, and monitor treatment response.
The PHQ-9 includes the nine signs/symptoms for the diagnosis of MDD in the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) and it is a widely-used mea-
sure to assess depression in various different settings [10], particularly in primary care [11]
where most patients with depression are first diagnosed and treated [12].
The Spanish version of the PHQ-9 is a reliable and valid measure of depression in hospital-
ized patients [13] and in primary care patients [14] in Spain. However, no studies have yet
examined the underlying factor structure of this instrument in the Spanish population. Studies
conducted in other Spanish-speaking populations have reported mixed results that support
both a one-factor structure [15–18] as well as a two-factor structure that includes both affective
and somatic symptoms [19, 20]. For instance, Huang et al [17] investigated the factor structure
of the PHQ-9 in a large sample of 5,053 primary care patients, finding that one general factor
accounted for the communality of all PHQ-9 items. Additionally, a Spanish version of the
scale developed in Mexico presented a unidimensional factor structure in a large sample
(n = 55,555) of Mexican women [16]. Some studies in different countries and settings also sup-
port a unidimensional structure [21, 22], although other studies have identified a two-factor
solution [23, 24].
When validating a scale such as the PHQ-9, it is important to examine whether that scale
remains structurally stable over time and across different groups (i.e., measurement invari-
ance). Examination (and confirmation) of factorial invariance is critical to assure comparabil-
ity of clinical outcomes. If invariance is not given, the interpretation of manifest scores (such
as feeling down or little pleasure in doing things) does not necessarily reflect the same latent
factor (i.e., depression) in different groups or at different times [25]. With regard to the PHQ-
9, little research has been conducted to determine whether this scale is invariant across various
demographic groups (other than gender) or over time. Petersen et al. [24] found that the
PHQ-9 was invariant in a sample of male and female primary care patients, and Chilcot et al.
[26] showed that the factor structure of this scale was invariant over time within a palliative
care population. To the best of our knowledge, no studies have yet investigated the invariance
of the PHQ-9 factor structure in any Spanish version of this instrument.
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Therefore, the present study had two primary aims. The first aim was to identify the factor
structure of the PHQ-9 in a sample of primary care patients in Spain. The second aim was to
examine the invariance of structural properties across various sociodemographic groups (i.e.,
gender, age, marital status, level of education, and employment situation) and over time.
Method
Patients
This study was conducted at 22 primary care centres included in the Psychology in Primary
Care (PsicAP) study [27] between the months of January and July (inclusive), 2016. The Psi-
cAP study is a randomized controlled trial developed to test the effectiveness of a group-deliv-
ered transdiagnostic cognitive behavioral therapy (TD-CBT) versus treatment as usual (TAU)
in the treatment of emotional disorders in primary care settings in Spain. During the study
inclusion period, all patients aged 18 to 65 years who consulted with their GP at any of these
22 PsicAP centers and who presented a diagnosis or suspected diagnosis of an emotional disor-
der (anxiety, depression or somatization disorder) were invited to participate in the clinical
trial. A total of 836 participants agreed to participate and were therefore included in the base-
line sample used to study the factor structure of the PHQ-9. Of these 836 patients, a subgroup
of 218 participants (who were finally included in the RCT and re-evaluated with the PHQ-9
three months later) was used to assess factorial invariance over time. At first contact, all candi-
dates were given a patient information sheet containing full details about the study purpose.
Subjects were required to sign an informed consent form to participate. The socio-demograph-
ics of the participants are shown in Table 1.
A total of 218 participants completed the PHQ-9 again 3 months after the initial baseline
assessment. The demographic characteristics of this smaller subsample was similar to the origi-
nal sample, with no significant differences in gender distribution (χ2 = 0.55, df = 1, p = .46),
age (t = 1.18, df = 1051, p = .24), or employment condition (χ2 = 1.95, df = 6, p = .92) (see
Table 1). However, significant differences were observed in the distribution of marital status
(χ2 = 11.75, df = 5, p = .03) and level of education (χ2 = 12.74, df = 5, p = .03). Given the actually
large sample size and the sensitivity of the χ2 statistic to sample size, these differences should
not be over-interpreted. In fact, the effect size of these differences were considerably low (Cra-
mer’s V level of education = .10; Cramer’s V Marital Status = .11). We further compared
whether missing cases significantly differed from non-missing cases on each PHQ-9 item. We
found statistically significant differences (without adjusting for multiple comparisons) in item
1 (loss of interest) [t (834) = 2.48, p = 0.01], and item 9 (suicidal ideation) [t (834) = 2.20,
p = 0.03]. However, the effect sizes for these differences were small (Hedges’ g< 0.2) and thus
unlikely to affect the results.
Measures
Patient Health Questionnaire-9 (PHQ-9) [9]. The PHQ-9 is part of the PHQ and consists of
nine items designed to assess the nine DSM-IV diagnostic criteria for MDD. The scales check
for the presence of the following symptoms over the previous two weeks: (a) depressed mood;
(b) anhedonia; (c) sleep problems; (d) feelings of tiredness; (e) changes in appetite or weight;
(f) feelings of guilt or worthlessness; (g) difficulty concentrating; (h) feelings of sluggishness or
worry; and (i) suicidal ideation. Items are answered on a four-point Likert scale from 0–3 as
follows: 0 (never), 1 (several days), 2 (more than half of the days), and 3 (most days). The Span-
ish version of the PHQ-9 was used in the present study. This version has demonstrated good
psychometric properties, as follows: internal consistency, McDonald’s ω = .89; 88% sensitivity;
80% specificity; and positive and negative predictive values of 92% and 72%, respectively [14].
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Procedure
GPs at the participating centers were asked to identify patients who presented signs or symp-
toms of anxiety, depression, or physical symptoms for which no biological cause could be
found. The GP then asked these candidates to participate in the study. Patients who agreed
then signed the informed consent form and were scheduled to meet with a clinical psycholo-
gist, who again provided the patients with verbal and written details about the study to be sure
they fully understood it. At this same appointment, the particpants were asked to complete a
computer-based version of the PHQ and the other study measures (n = 836). Patients with
impaired vision received assistance in completing the questionnaires. Paper versions of these
instruments were provided to patients who had difficulties using the computer.
A subsample of 218 cases was assessed at the 3-month follow-up. This subsample received
one of the two treatments tested in the randomized controlled trial: (i) TAU, mainly
Table 1. Demographics characteristics of sample.
Total sample Follow-up subsample
(N = 836) (n = 218)
N % n %
Gender
Female 639 76.4 172 78.9
Male 197 23.5 46 21.1
Age group
 19 10 1.2 1 0.5
20–39 308 36.8 76 34.9
40–59 438 52.4 120 55.0
 60 80 9.6 21 9.6
Marital status
Married 411 49.2 130 59.6
Divorced 77 9.2 12 5.5
Widowed 24 2.9 8 3.7
Separated 51 6.1 5 2.3
Never married 162 19.4 37 17
Unmarried 111 13.1 26 11.9
Level of education
No schooling 15 1.8 0 0
Basic education 248 29.7 49 22.5
Secondary education 165 19.6 47 21.6
High School 170 20.4 53 24.3
Bachelor 197 23.5 60 27.5
Master/doctorate 41 5.0 9 4.1
Employment situation
Part-time employee 119 14.2 31 14.2
Employed full time 308 36.8 77 35.5
Unemployed, in search of work 201 24.0 53 24.3
Unemployed, not looking for work 107 12.9 27 12.4
Temporary incapacity to work 44 5.3 10 4.6
Permanent incapacity to work 12 1.4 5 2.3
Retired 45 5.4 15 6.9
https://doi.org/10.1371/journal.pone.0193356.t001
Factor structure and measurement invariance of PHQ-9
PLOS ONE | https://doi.org/10.1371/journal.pone.0193356 February 23, 2018 4 / 16
pharmacological treatment by the GP, or (ii) seven 90-minute group sessions of TD-CBT
delivered over 12 to 14 weeks (for further details see [27]).
Ethical aspects
The study was conducted in accordance with the Declaration of Helsinki. This project is sup-
ported by the Psicofundacio´n (Spanish Foundation for the Promotion, Scientific and Profes-
sional Development of Psychology) and approved by the Corporate Clinical Research Ethics
Committee of primary care of Valencia (CEIC-APCV), Spain, as the national research ethics
committee coordinator, and the Spanish Agency of Medicines and Medical Devices (AEMPS)
(EUDRACT: 2013-001955-11 and Protocol Code: ISRCTN58437086).
The study was conducted in accordance with the Spanish Law on Data Protection. Patient
participation in the study was voluntary and participants were able to withdraw at any time
without explanation and without negative consequences for future medical care.
Statistical analysis
Initially, an exploratory analysis of the data was performed to explore the behaviour of the vari-
ables, to evaluate the quality of the data, and to check that requirements of statistical tests were
met. We checked for the existence of atypical cases, missing values and compliance with the
statistical assumptions (linearity, and univariate and multivariate normality). A confirmatory
factor analysis (CFA) was performed using maximum-likelihood (ML) as an estimation
method; the AMOS 20 program [28] was used for these analyses. A one-factor model was spec-
ified in which the nine PHQ-9 items loaded on a single factor (called "depression") and an
alternative two-factor model in which 3 items loaded on the "somatic" factor and 6 items in the
"cognitive-affective" factor, corresponding with previous research on PHQ structure.
Multiple indices were examined to determine model fit: (a) The chi-squared statistic (χ2)
was reported following conventions. However, given its sensitivity to sample size, is becomes
usually significant. However, differences in χ2 can be interpreted to compare nested models.
Additionally, we considered (b) the comparative fit index (CFI); (c) the Tucker-Lewis index
(TLI); and (d) the root mean square error of approximation (RMSEA). To interpret these indi-
ces, we used the critical values previously recommended [29, 30]. Specifically, values > .90 and
.95 for the CFI and TLI were considered benchmarks for acceptable and good fit, respectively;
and RMSEA values of< .08 and .06 were benchmarks for acceptable and good fit, respectively.
Analyses of multiple-group invariance were conducted to determine the extent to which
the factor structure was comparable across various sociodemographic groups (i.e., gender, age,
marital status, level of education and employment situation) and over time. We followed the
measurement invariance procedures outlined by Brown [31]. Factorial invariance is essential
to provide meaningful comparisons of scores across groups or across time. Therefore, four lev-
els of measurement invariance were sequentially tested (configural, weak, strong, and strict
invariance), where each level introduces more equality constraints across groups. Configural
invariance implies that the pattern of fixed and free factor loadings are equivalent. Weak facto-
rial invariance examines the equivalence of factor loadings (i.e., items assess the latent variable
in the same way across groups or time). Strong factorial invariance examines the equality of
latent means, implying that any differences in means on the scale are due to true differences in
means across groups or time. Finally, strict invariance—the most restrictive level of factorial
invariance—examines the invariant item residual variances and this implies that group differ-
ences in variances of scale scores are due only to group differences in depression variances,
since error variances were constant across groups. Configural invariance is supported if the
same unconstrained factor structure simultaneously fit for the split groups yields a good fit.
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After testing configural invariance, we examined weak/metric invariance. The fit of the
restricted model (equal factor loadings across groups) and the free model, were compared in
terms of their χ2 values. A non-significant increase in the χ2 value (relative to df) in the con-
strained model relative to the unconstrained model indicated that the constrains across groups
were possible. As an additional criterion, the change in the CFI coefficient was considered. If
the drop in CFI of the constrained model relative to the unconstrained model did not exceed
0.01, the constrained model was accepted [32]. The ΔCFI criterion was argued to be superior
to Δ χ2, as it is less sensitive to sample size [33]. We proceeded analogously to tests strong/sca-
lar invariance and strict invariance.
Results
Exploratory and descriptive analysis
The Z scores for each item were calculated and univariate values considered atypical were
those values outside the Z ± 3 range [34]. The existence of atypical multivariate cases was
assessed using the Mahalanobis distance (D2) statistical procedure. There were no univariate
atypical cases and only 7 cases showed a statistically significant distance from the centroid of
the group (p< .001). In the analysis of missing values, the items presented < 5% of lost cases.
Considering the low proportion of missing treatment values, "listwise deletion" was applied in
accordance with published recommendations [35].
Based on the criteria proposed by George and Mallery [34], all items presented a distribu-
tion that was close to normal given that asymmetry and kurtosis values were between ±2 (see
Table 2). Multivariate normality showed a Mardia index of 7.24, indicating there was no sub-
stantial deviation from normal distribution. To test the linearity assumption of the relations,
linear and curvilinear estimates were calculated between pairs of items. In all cases, the linear
function was superior to the curvilinear function, thus confirming the linearity assumption. S1
Table shows the inter-item correlation matrix for the PHQ-9 items.
Confirmatory factor analysis
Since normality assumptions were met, the maximum-likelihood (ML) was used as an estima-
tion method. Both the one-factor and two-factor models presented acceptable values for the
CFI and GFI indexes, but exceeded an RMSEA of .08. The model fit could be substantially
improved when error terms of PHQ-9 items 1 and 2 were allowed to be correlated, reflecting
that both items shared similarity that is not explained by the general depression factor. The fit
indexes obtained for both models are summarized in Table 3. All items displayed substantial
factor saturation, as indicated by their high factor loading (all λ .54-.77; all p< 0.05; see Fig 1).
The two-factor model yielded a better fit in both the original model and the models that
Table 2. Descriptive statistics of the PHQ-9 items.
M SD Skewness Kurtosis
1. Little interest or pleasure 1.70 1.01 - 0.05 - 1.20
2. Feeling down, depressed, or hopeless 1.81 0.99 - 0.13 - 1.21
3. Trouble falling/staying asleep/sleeping too much 1.75 1.10 - 0.23 - 1.30
4. Feeling tired or having little energy 1.86 1.03 - 0.30 - 1.20
5. Poor appetite or overeating 1.52 1.12 0.00 - 1.36
6. Feeling bad about yourself/failure 1.57 1.16 - 0.02 - 1.46
7. Trouble concentrating 1.36 1.07 0.26 - 1.18
8. Moving or speaking so slowly 1.21 1.03 0.40 - 1.00
9. Thoughts that you would be better off dead 0.61 0.90 1.46 1.18
https://doi.org/10.1371/journal.pone.0193356.t002
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additionally allowed for the error correlations of PHQ items 1 and 2. However, the "somatic"
and "cognitive-affective" factors were found to be highly correlated (r = .86). This indicates
substantial overlap between the two factors and complicates the interpretation of correspond-
ing test scores for diagnostic purposes.
Invariance across sociodemographic groups
Given the known issues of using the ML estimation method with ordinal data, we used the ML
and the Weighted Least-Squares (WLS) methods to perform the CFA. The results obtained with
both estimation methods (ML and WLS) were highly similar and therefore we report only the
results of the ML estimation. To determine whether patient gender affected the measurement
model, the sample was split into men (23.6%) and women (76.4%), and constrains were intro-
duced to test if parameters could be constrained across both groups. Then, we compared the fit
of the constrained model to that of the free model were parameters were estimated indepen-
dently in each group. Both models were compared in terms of Δχ2 and, more importantly, by
ΔCFI: The more constrained model was accepted if the constraints did not significantly deterio-
rate model fit [29, 32]. Following Brown [31], we first examined the fit of the single-sample one-
factor solutions within the specific subsamples (e.g., men-only and women-only subsample)
separately. Next, we tested four levels of invariance (configural invariance, weak invariance,
strong invariance, and strict invariance) using a series of increasingly restrictive models. The
Table 3. Model fit.
Fit indexes
χ2 df p CFI GFI RMSEA
M1: One factor 286,03 27 .00 .91 .92 .10
M2: Two factors 213,12 26 .00 .94 .94 .09
M3: One factor 182,15 26 .00 .95 .95 .08
M4: Two factors 126,73 25 .00 .96 .97 .07
 Error terms of PHQ item 1 and 2 were allowed to be correlated.
https://doi.org/10.1371/journal.pone.0193356.t003
Fig 1. One-factor and two-factor models of the PHQ-9 items.
https://doi.org/10.1371/journal.pone.0193356.g001
Factor structure and measurement invariance of PHQ-9
PLOS ONE | https://doi.org/10.1371/journal.pone.0193356 February 23, 2018 7 / 16
single-sample solutions for the one-factor model based on the men-only and women-only sub-
samples are shown in Table 4. Both subsamples were associated with good model fit. The test of
configural invariance was supported, as evidenced by fit indices meeting the benchmarks for
adequate fit (RMSEA = .058, CFI = .95, TLI = .93). All levels of invariance up to strict invariance
could be assumed across gender, as evidenced by a non-significant drop in model fit (ΔCFI<
.01) for the successively more constrained models (Table 4).
Using the same procedure, the model was evaluated to check for invariance across age
(Table 4). To this end, participants were divided into a younger adult group (20 to 39 years of
age) and an older adult group (40 to 59 years old) following the criteria recommended by
Table 4. Fit statistics for multi-group confirmatory factor analysis by gender, age, marital status, level of education, and employment situation.
χ2 Df RMSEA CFI TLI ΔCFI Δ χ2 Δ df
Gender
Women 128.77 26 .079 0.95 0.93 — — —
Men 68.40 26 .070 0.95 0.93 — — —
Configural Invariance 197.26 52 .058 0.95 0.93 — — —
Weak Invariance 204.14 60 .054 0.95 0.94 0.00 6.88 8
Strong Invariance 262.71 69 .058 0.94 0.93 0.01 58.57 9
Strict Invariance 280.67 79 .056 0.94 0.94 0.00 17.96 10
Age
Young adults (20–39) 102.93 26 .087 0.93 0.90 — — —
Adults (40–59) 107.24 26 .085 0.95 0.93 — — —
Configural Invariance 210.19 52 .064 0.94 0.92 — — —
Weak Invariance 214.48 60 .059 0.94 0.93 0.00 4.29 8
Strong Invariance 226.82 69 .055 0.94 0.94 0.00 12.34 9
Strict Invariance 246.18 79 .053 0.94 0.94 0.00 19.36 10
Marital Status
Paired 132.40 26 .080 0.94 0.92 — — —
Unpaired 76.65 26 .079 0.95 0.94 — — —
Configural Invariance 209.05 52 .060 0.95 0.93 — — —
Weak Invariance 218.68 60 .057 0.95 0.94 0.00 9.63 8
Strong Invariance 245.92 69 .056 0.94 0.94 0.01 27.24 9
Strict Invariance 263.18 79 .053 0.94 0.94 0.00 17.26 10
Level of Education
Basic education 49.16 26 .060 0.97 0.96 — — —
Secondary education 116.53 26 .088 0.93 0.90 — — —
High education 54.82 26 .073 0.96 0.95 — — —
Configural Invariance 220.49 78 .047 0.95 0.93 — — —
Weak Invariance 244.22 94 .044 0.95 0.94 0.00 23.73 16
Strong Invariance 293.04 112 .045 0.94 0.94 0.01 48.82 18
Strict Invariance 334.64 132 .044 0.93 0.94 0.01 41.60 20
Employment situation
Employed 111.94 26 .089 0.94 0.92 — — —
Unemployed 112.51 26 .090 0.94 0.92 — — —
Configural Invariance 224.46 52 .063 0.94 0.92 — — —
Weak Invariance 244.62 60 .061 0.94 0.93 0.00 20.16 8
Strong Invariance 271.46 69 .600 0.93 0.93 0.01 26.84 9
Strict Invariance 276.24 79 .055 0.93 0.94 0.00 4.78 10
p<0.01
https://doi.org/10.1371/journal.pone.0193356.t004
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Martı´n Ruiz [36]. Adolescents (< 20 years) and elderly (> 60 years) were not included in this
analysis because they did not reach the minimum group sample size (> 200 cases) [37]. After
dividing patients into younger adults (n = 316) and older adults (n = 433), successively stricter
constrains were tested to test for configural, weak, strong, and strict invariance. The single-
sample solutions for the one-factor model based on the younger adult group and the older adult
group subsamples are shown in Table 4. A good model fit was obtained for both subsamples.
Configural invariance was supported by fit indices meeting benchmarks for adequate fit
(RMSEA = .064, CFI = .94, TLI = .92). Weak, strong, and strict invariance could be assumed
across age groups, as evidenced by a non-significant drop in model fit (Δχ2 = n.s. and ΔCFI<
.01) for the successively stricter models (Table 4).
To evaluate invariance across different groups of marital status, participants were split
into a "paired group" (married and cohabiting participants; n = 522) and "unpaired group”
(divorced, separated, widowed, and unmarried; n = 314). Successively stricter constrains were
tested to evaluate configural, weak, strong, and strict invariance. The single-sample solutions
for the one-factor model based on the paired group and unpaired group subsamples are shown
in Table 4, each showing a good model fit. Configural invariance was supported by fit indices
meeting benchmarks for adequate fit (RMSEA = .063, CFI = .94, TLI = .92). Weak, strong, and
strict invariance could be assumed across pairing status, as evidenced by a non-significant
drop in model fit for the stricter models (ΔCFI< .01) (Table 4).
To evaluate invariance across levels of education, participants were split into three groups:
basic education group (n = 248); secondary education group (n = 335) and high education
(n = 238). Successively stricter constrains were tested to evaluate configural, weak, strong, and
strict invariance. Configural invariance was supported by fit indices meeting the benchmarks
for adequate fit (RMSEA = .047, CFI = .95, TLI = .93). Weak, strong, and strict invariance
could be assumed across educational levels, as evidenced by a non-significant drop in model
fit for the stricter models (ΔCFI< .01) (Table 4).
To test invariance across employment conditions, participants were divided into two
groups, an employed group (full and part-time employment; n = 422), and an unemployed
group (unemployed, incapacity to work, and retired; n = 408). Successively stricter constrains
were tested across groups to evaluate configural, weak, strong, and strict invariance. Model fits
obtained for the employed subsample and for the unemployed group subsample are shown in
Table 4. These were good for both subsamples. Configural invariance was supported by fit
indices meeting the benchmarks for adequate fit (RMSEA = .063, CFI = .94, TLI = .92). Weak,
strong, and strict invariance could be assumed across employment conditions, as evidenced by
a non-significant drop in model fit for the stricter models (ΔCFI< .01) (Table 4).
Longitudinal invariance
Temporal stability, also known as longitudinal invariance, is important to make sure the
instrument in question measures the same latent constructs in the same manner over time.
Using an analogous procedure, we evaluated whether the measurement model was invariant
across time (i.e., a 3-month interval from baseline to the 3-month assessment). Applying suc-
cessively stricter parameter constrains, the analyses supported weak (Δχ2 = 60.70, df = 8, p =
.57; ΔCFI< .01), strong (Δχ2 = 117.87, df = 17, p< .01; ΔCFI< .01), and strict invariance
(Δχ2 = 117.87, df = 26, p< .01; ΔCFI< .01) across time.
Discussion
To our knowledge, this is the first study to examine the factor structure of the Spanish version
of the PHQ-9 in the Spanish population. The results of the confirmatory factor analyses in the
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data collected from this primary care sample identified one-factor and two-factor models, both
of which met all the pre-established fit criteria. However, given that the "somatic" and "cogni-
tive-affective" factors identified in the two-factor model were highly correlated (r = .86), the
unidimensional model is more parsimonious and, hence, the preferred solution. Importantly,
this one-factorial structure was found to be invariant across various demographic groups,
including gender, age, marital status, level of education, and employment situation. Thus, the
PHQ-9 is applicable in the Spanish population and derived scores can be validly compared
without need for specific sociodemographic adjustments. Additionally, the one-factor struc-
ture was found to be stable over a 3-month period.
Consistent with the results reported in previous studies of Mexican females [16] and a US-
based Spanish-speaking Latino population [15, 17, 18], our findings support the one-factor
solution for the Spanish version of the PHQ-9. Most studies examining the factor structure of
the PHQ-9 have corroborated the unidimensionality of the scale [21, 22, 38–40]. However,
some authors have reported a two-factor structure comprising a cognitive–affective and a
somatic dimension [23, 24, 26, 41, 42]. This discrepancy between studies is likely due to differ-
ences in patient populations. The current study mainly consisted of individuals with mild to
moderate emotional distress in a primary care setting, which is the kind of heterogeneous sam-
ple for which the PHQ-9 was originally developed and validated to diagnose depression [9]. By
contrast, studies that have found a two-factor solution have been conducted in populations
that predominately present comorbid physical conditions such as spinal cord injury [42] or
cancer [26, 41]; therefore, somatic factor loading may be attributable to possible confounding
effects of the physical illness [43].
Petersen et al [24] found that a two-factor model with five ‘somatic’ items and four ‘affec-
tive/non-somatic’ items yielded the best fit in a sample of primary care patients. The one-factor
and two-factor structures examined in our study displayed a poor model fit in the study car-
ried out by Petersen et al [24]. However, it is important to note that all the patients in their
sample had a diagnosis of major depression (PHQ-9 >9) for which antidepressive treatment
was indicated. As those authors suggested, their relatively homogeneous sample may have
resulted in range restriction in the measures, thereby attenuating correlations among variables.
When PHQ-9 is used with more heterogeneous samples, it is more likely to produce a one-fac-
tor solution because the variance is larger and therefore the items are more likely to load on
one factor [24]. Alternatively, it may well be that somatic features are more relevant in the
diagnosis of depression in samples that include individuals with moderate to severe clinical
conditions. It is worth noting that while the one-factor model seems to be a more parsimoni-
ous solution in our study, the two-factor model (with a factor of 3 ‘somatic’ items) also dis-
played a decent model fit.
Gender invariance, which may be considered a prerequisite for making quantitative com-
parisons, adds important support for the validity of the PHQ-9 as a self-report screening
instrument because it indicates that the measurement model of the latent depression construct
is comparable in both sexes. This implies that differences in observed test scores between men
and women reflect true differences in depression rather than an artefact of the measurement
method. Epidemiological studies have consistently shown a higher prevalence of MDD in
women than in men [44, 45]. In Spain, the ESEMED study found 12-month prevalence rates
for MDD of 2.2% for males and 5.6% for females. Moreover, this difference was even more
pronounced for "any depressive disorder"; 2.3% for males vs. 6.3% for females [3]. Although
we found a statically significant difference between men and women in mean PHQ-9 scores,
the effect size was small.
Apart from gender, we also tested invariance across other sociodemographic characteristics
such as age, marital status, level of education, and employment situation. Invariance could be
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assumed for all of these variables when patients were divided into comparable groups accord-
ing to the criteria recommended by Martı´n Ruiz [36] and Barret [37]. These results strengthen
the validity of the PHQ-9 as a screening tool in settings (such as primary care) where popula-
tion heterogeneity is substantial.
To precisely measure the true change and inter-individual differences, it is also critical to
examine if the PHQ-9 consistently measures the same construct over time. Previous studies
have reported mixed results for invariance across time. One study [26] found that the PHQ-9
was invariant over time in a sample of patients newly referred to a palliative care service. In
that study, patients were assessed within one-week of referral (time 1) and then again 4-weeks
later (time 2). The observed factor structure of the PHQ-9 appeared to be stable in this setting
since the two-factor model had good fit at both time points. By contrast, other studies in
patients with spinal cord injuries have reported considerable instability of the factor structure
over time [42, 43]. In our results, the factor structure was equivalent at two different time
points (baseline and at 3 months) during which patients received pharmacological and/or psy-
chological treatment for emotional disorders in a primary care setting [27]. This invariance
indicates that changes in PHQ-9 scores over time reflect true changes in the underlying latent
construct (i.e. depression) rather changes in the assessment or structure of the scale. The effect
size for this change was large (g = 0.78) and we believe this change can be reasonably attributed
to the effects of treatment.
Study strengths and limitations
The main strengths of the present study is the relatively large, heterogeneous sample of
patients with emotional disorders from 22 primary care centres across Spain. It is worth noting
that in Spain, as in many other countries, the vast majority of patients with emotional disor-
ders are diagnosed and treated only in the primary care setting [46]. Thus, our sample can be
considered representative of persons with mild-to-moderate emotional disorders seeking help.
One limitation of our study is that the PHQ-9 may have a different structure in individuals in
need of specialized services, or those with more severe clinical conditions; and this possibility
could not be tested in the current study. We did not assess the concurrent validity of the Span-
ish version of the PHQ-9 against a semi-structured clinical interview to establish empirically-
derived cutoff levels. However, the good sensitivity and specificity of the PHQ-9 have already
been demonstrated in different populations [47], including the Spanish cultural context [13,
14]. The subsample of patients assessed at follow-up was part of an ongoing RCT to compare
group CBT to TAU in a primary care setting. As a result, the subsample assessed at follow-up
may not have accurately reflected the overall sample assessed at baseline. Indeed, some small
but significant differences were observed in terms of marital status and level of education
between baseline and follow up assessments. We also found small but statically significant dif-
ferences between the baseline sample and the subsample used to assess factorial invariance
over time on two items of the PHQ-9. Although these differences were small (Hedges’ g< 0.2)
and significance was not adjusted for multiple comparisons, the findings obtained from this
subsample (i.e., the results of invariance over time) need to be interpreted with caution.
Finally, a potential limitation regarding the data used to calculate invariance over time is that
these data came from a RCT, which implies an intervention between two time-points (i.e.,
baseline and assessment). However, most patients who seek treatment for psychological dis-
tress in primary care will receive some kind of pharmacological or psychological treatment
from their GP, and thus the fact that invariance over time was based on a subsample of patients
included in a RCT (and, therefore, who received some type of intervention) may actually
reflect the real-world context in which PHQ-9 is likely to be used. Thus, it might be said that
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the PHQ-9 structure is invariant regardless of treatment for emotional disorders. Indeed, the
fact that strict invariance holds provides additional support for the robustness of the latent
structure of the scale.
Clinical and research implications
Our findings have several important clinical and research implications. First, given the high
prevalence rates of emotional disorders and, particularly, depression among primary care
patients, GPs need well-validated screening tools that are easy to administer, score, and inter-
pret. The unidimensional factor structure of the PHQ-9 allows clinicians to use the scale with-
out the need for complicated scoring algorithms. Thus, clinicians and researchers can rely on a
global score and a single cut-off score. Second, measurement invariance across multiple groups
provides empirical support to allow clinicians and researchers to interpret between-group
comparisons as true differences in depression intensity and not a measurement artifact. For
instance, establishing gender invariance (or non-invariance) is critical for studies with a gen-
der perspective. Finally, invariance measurement across time further supports the utility of the
PHQ-9 as a simple tool for monitoring treatment response.
Conclusions
The current study provides important evidence regarding the construct validity and multi-
group factorial and time invariance of the Spanish version of the PHQ-9 in primary care set-
tings in Spain. In the present study, both the one-factor and the two-factor models displayed
good model fit. The two-factor model (with a factor of three ‘somatic’ items highly correlated
to the ‘cognitive-affective’ factor) displayed slightly better fit, while the one-factor model was
preferred for its parsimony. The one-factor model was additionally demonstrated to be invari-
ant across demographic groups and across time. The findings presented here suggest that pri-
mary care physicians in Spain can use the PHQ-9 to assess depression severity and to reliably
monitor changes over time.
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